Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

GE HealthCare acquires SOFIE Biosciences for $945M

PUBLIC · GEHCOct 13, 2026

Acquiring Company

GE HealthCare Technologies

Acquired Company

SOFIE Biosciences

ChicagoCulver CityOtherInformation TechnologyBiotechnologyHealth CareMedicalBiotechnology

Description

GE HealthCare Technologies has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition enhances GE HealthCare's capabilities in the U.S. PET radiopharmaceutical market and includes rights to a novel imaging candidate. The deal is expected to strengthen GE HealthCare’s position in cancer diagnostics and imaging solutions.

Company Information

Company

GE HealthCare Technologies

Location

Chicago, Illinois, United States

About

GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. With a focus on precision care strategy, GE HealthCare aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states.

Fundz sees it the moment GE HealthCare Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Peter
Senior decision-maker at this company
••••••••@••••••••

See Peter's verified email →

Agnieszka
Senior decision-maker at this company
••••••••@••••••••

See Agnieszka's verified email →

Sylvain
Senior decision-maker at this company
••••••••@••••••••

See Sylvain's verified email →

Ehab
Likely contact at this company
••••••••@••••••••

See Ehab's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for GE HealthCare Technologies's next move

Learn about Strategic plan

Frequently asked

Who acquired SOFIE Biosciences?

SOFIE Biosciences was acquired by GE HealthCare Technologies, based in Chicago. The deal was reported on October 13, 2026. GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. GE HealthCare Technologies is publicly traded (GEHC) and operates in Other.

When did GE HealthCare Technologies acquire SOFIE Biosciences?

GE HealthCare Technologies's acquisition of SOFIE Biosciences was reported on October 13, 2026. GE HealthCare Technologies has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition enhances GE HealthCare's capabilities in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does SOFIE Biosciences do?

SOFIE Biosciences is a leading innovator in the field of radiopharmaceuticals. The company develops advanced imaging agents for cancer diagnosis and treatment. Its products aim to improve the accuracy and effectiveness of diagnostic imaging. It is privately held, operating in Biotechnology, and is based in Culver City.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.